Low SMI may reduce metabolic reserve and impair the secretion of protective myokines (e.g., irisin and IL-10), leading to weakened anti-inflammatory capacity and muscle regeneration, whereas high BRI reflects visceral fat accumulation that promotes systemic inflammation, endothelial dysfunction, and pro-thrombotic states. The gene discussed is FNDC5; the disease is endothelial dysfunction.